Australian shares are expected to slip into the red at market open Friday as investors follow losses from Wall Street overnight.
The Nasdaq and the S&P 500 shed 0.2% each on Thursday, with Tesla driving the losses following a drop in vehicle deliveries for 2024. The Dow Jones Industrial Average was down 0.4%.
In macroeconomic news, the commodity price index rose 0.6% month over month in December 2024 in special drawing rights (SDR) terms, following a revised 1.3% increase in the prior month, preliminary data from the Reserve Bank of Australia showed Thursday.
In corporate news, Imugene (ASX:IMU) dosed the first Australian patient in the Phase 1b clinical trial of its azer-cel therapy, which is being assessed as a potential treatment for non-Hodgkin's lymphoma.
Arcadium Lithium (ASX:LTM) and Livent entered into a second supplemental indenture on Jan. 1.
UBS Securities Australia ceased to be a substantial holder in SG Fleet Group (ASX:SGF).
Australia's benchmark index rose 0.5%, or 42.10 points, Thursday to close at 8,201.20.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。